One of the most persistent problems in clinical genetic testing is interpretation of compound heterozygotes. Particularly problematic are recessive genes for which compound heterozygosity is relatively common, such as CYP21A2 (cytochrome P450, family 21, subfamily A, polypeptide 2), the gene responsible for Ͼ90% of congenital adrenal hyperplasia (CAH) 1 cases. Next-generation sequencing (NGS) methods provide a way to both sequence and phase genes; however, the techniques are largely qualitative and do not provide a quantitative measure of confidence in the cis/trans call. To date, an intuitive and reliable statistic to summarize the quality of a phase call is not available for diagnostic sequencing. Without such an indicator, incorrect phase calls can be made easily when sequence coverage is low or when errors are introduced during library preparation or amplification.
Previously, we described a statistical method to generate probability scores and associated confidence intervals for each base in a tandem sequence of heterozygous positions (1 ). That method is based on stepwise analysis of sequential pairs of heterozygous loci. Although the method is functional, it suffers in regions where coverage is low and heterozygotes are far apart. It is also incapable of using bridged reads that cover nonsequential heterozygous positions concurrently. We have remedied these problems by creating a directed network that represents all of the bridged reads in a region of interest. Markov chain analysis (2 ) is used to calculate the probabilities for cis relationships between all of the bases in a pair of compound heterozygotes (see Supplemental Fig. 1 , which accompanies the online version of this letter at http:// www.clinchem.org/content/vol61/ issue2). This strategy uses many more bridged reads than the previous method, allowing accurate analysis even through areas of low coverage. To produce confidence intervals, the network is resampled and the analysis rerun 1000 times, creating a set of probability distributions. Each distribution represents the probability of a cis relationship between 2 bases.
In an errorless data set, one probability distribution would exist completely at 100% while all others would be found at 0%. Error is introduced by inaccurate mapping, PCR recombination, and chimeric ligation during library prep, however, so the calculated probability distributions will shift toward 50% and broaden. Even in these circumstances, correct calls can be made, if we can accurately assess uncertainty in the system. A measure of this uncertainty is found in the overlap between probability distributions and can be calculated using the Bhattacharyya coefficient, B (3). This is a crude integration of the area shared by 2 distributions and thus provides a quantitative assessment of the quality of a cis/trans call.
To demonstrate the effectiveness of our new method, we evaluated 13 specimens that had previously been tested for CAH and found to have multiple heterozygous disease-causing mutations or variants of unknown significance. Phases for each sample were assigned by testing family members and, in some cases, additional molecular testing. Using our improved method, we were able to obtain sequence and phase information directly from the proband's NGS analysis (see online Supplementary Table) . In 12 of 13 cases, there was no overlap between probability distributions (B ϭ 0), providing unequivocal cis/ trans calls, although each sample had accumulated a low percentage of chimeric read-pairs through recombination during long-range PCR amplification. One sample had slight overlap (B ϭ 0.64%), indicating a small amount of uncertainty in the result (Fig. 1) . On further investigation, we found that this sample had low bridged coverage (64 reads) and a relatively high error rate (16% chimeric). High coverage and low total experimental/sequencing error rates result in narrow probability distributions that are centered near 0% and near 100%, respectively (A). By contrast, low coverage broadens the probability distributions while high total error rates shift the means toward 50% (B). The Bhattacharyya coefficient, B, is a measure of the overlap between distributions and thus, a score representing uncertainty in the phase result. -439 (2015) Letters to the Editor Although inference of the proper phase in this case is still obvious, with a chance of an erroneous phase assignment of only 0.64%, the B-score acts as a warning signal, alerting the user to the need for further investigation of the data.
Clinical Chemistry
With the rapid adoption of NGS in the clinical testing arena, our ability to collect raw data has far outpaced our capacity to analyze and interpret results. Although there have been numerous computational tools developed for these purposes, most of them have been designed for research purposes and lack the proper statistical underpinnings that are required at the level of clinical interpretation.
Phasing is a good example of an unmet clinical need. Accurate phasing of compound heterozygous alleles is an important and common problem for many clinical sequencing laboratories. Our method offers a simple yet robust solution that is capable of providing a statically relevant score to help laboratory personnel interpret haplotypes in the presence of experimental error. Our testing scenario showed complete concordance with much more laborious conventional phasing methods. The method is in principle applicable to any gene/ gene locus and capable of phasing across significant genetic distances. 
